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TerbinafineAbstract The isolated active compound ‘‘F12” from the culture media of the Streptomyces sp.
KH-F12 was identified using different spectroscopic techniques. Both 1D- and 2D-NMR as well
as HRESIMS were utilized to characterize the structure of the isolated compound. ‘F12” was found
to be the known systemic antifungal drug terbinafine marketed under the name ‘‘Lamisil”. Full
analysis of the COSY, HSQC and HMBC enables the full assignment of proton and carbon atoms.
Terbinafine is a synthetic allylamine and is reported here for the first time from natural source.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Actinomycetes are the source of approximately two-thirds of
the discovered microbial bioactive substances (Berdy, 2005;
Demain and Sanchez, 2009). The discovery of new antibiotics
from Actinomycetes decreased dramatically in the recent years
as a result of frequent rediscovery rate of known compounds
(Stach, 2010; Subramani and Aalbersberg, 2013) as well as
the exhaustion of the common resources (Demain and
Sanchez, 2009). However, the American Academy of Microbi-ology estimated that less than 1% of bacterial species are dis-
covered, and millions of microbes in the environment are yet to
be discovered (Cragg and Newman, 2005).
The need for new, more effective and safe antifungal com-
pounds is a major challenge to the pharmaceutical industry
(Dharumaduari et al., 2008). Many antifungal agents were dis-
covered from Actinomycetes. Pyrrolomycin A produced from
the culture of Actinosporangium vitaminophilum SF-2080
showed broad spectrum antimicrobial activity including anti-
fungal effect (Parry et al., 2011). The monocyclic nitrated anti-
fungal agent ayamycin was isolated from Nocardia sp. (El-
Gendy et al., 2008; Parry et al., 2011). The nitrophenyl pyrone
aureothin was discovered among other members from Strepto-
myces spp. (Parry et al., 2011). Another antifungal antimicro-
bial and antiparasitic compounds bafilomycins were found in
Streptomyces spp. (Yu et al., 2011). The antifungal caeru-
lomycin A was reported from both Streptomyces caeruleus
and Actinoalloateichus cyanogriseus (Ambavane et al., 2014).
Previously, we reported on the isolation compound desig-
nated as F12 from Streptomyces sp. recovered from a soil sam-aceutical
2 M.S. Abdel-Kader, M.M. Muharrample of Adilamm, Riyadh Province (KSA), with promising anti-
fungal activity (Muharram and Abdel-Kader, 2014). In the
present work we report on the full characterization of F12.
2. Materials and methods
2.1. General experimental procedures
Ultraviolet absorption spectra were obtained in methanol on a
Unicum Heyios a UV-Visible spectrophotometer. Optical rota-
tions were recorded on a Jasco P-2000 Polarimeter. 1H,
13C NMR spectra as well as 2D-NMR experiments (COSY,
HSQC and HMBC) were obtained using standard Bruker pro-
gram on a UltraShield Plus 500 MHz (Bruker) (NMR Unite at
the College of Pharmacy, Salman Bin Abdulaziz University)
spectrometer operating at 500 MHz for proton and 125 MHz
for carbon, respectively. The chemical shift values are reported
in d (ppm) relative to the residual solvent peak, and the cou-
pling constants (J) are reported in Hertz (Hz). HRESIMS
was obtained using Agilent 6220 Accurate Mass TOF (Time
of Flight) LC/MS Spectrometer (Analytical Services Unite at
Department of Chemistry, Virginia Polytechnic Institute andN
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Figure 1 Structure of ‘‘F12”.
Table 1 1H NMR and 13C NMR data of F-12 in ppm (multiplicity
Pos. CDCl3
1H NMR 13C NMR
2 2.97 (d, J= 6.8) 60.7
3 5.90 (dt, J= 6.8, 15.8) 139.4
4 5.59 (d, J= 15.8) 114.9
5 – 78.5
6 – 99.4
7 – 29.0
8–10 1.07 (s, 9H) 31.7
10 3.62 (s, 2H) 60.5
20 – 135.4
30 7.18 (m) 129.0
40 7.29 (m) 127.0
50 8.32 (d, J= 8.3) 126.7
50a – 135.3
60 7.64 (d, J= 7.6) 129.6
70 7.18 (m) 125.7
80 7.29 (m) 126.8
90 7.56 (d, J= 8.5) 129.4
90a – 133.8
N-CH3 1.95 (s, 3H) 42.6
a Assignments were done based on DEPT, COSY, HSQC and HMBC
Please cite this article in press as: Abdel-Kader, M.S., Muharram, M.M. New micr
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ESI in the positive mode.
2.2. Sample collection and isolation of actinomycetes
Soil samples were collected from Adilamm (KSA) as previ-
ously described (Muharram et al., 2013). The isolate KH-
F12 showed promising antifungal activity. Fermentation was
carried out in ISP2 broth medium (International Streptomyces
Project medium No. 2) also known as Yeast Malt Agar (YM
Agar) for 10 days following the previously reported procedures
with little modifications (Muharram and Abdel-Kader, 2014).
The medium was inoculated with 3 ml/100 ml medium of a
pre-culture broth of isolate KH-F12 prepared with the same
medium and incubated at 30 C for 2 days. The cultures were
incubated on a rotary shaker (200 rpm) at 30 C for 10 days.
Fermentations were repeated to obtain a total of 5.0 L of cul-
ture broth. At the end of the fermentation cycle the culture was
filtered and the supernatant was separated by centrifuging at
8000 rpm for 15 min. The supernatant was extracted with
CHCl3 (6 500 ml). The CHCl3 extract was concentrated
using rotary vacuum evaporator and the semi solid residue
(1.2 g) was subjected to Vacuum Liquid Chromatography
(VLC) over RP18 230–400 mesh (80 g, 7 cm i.d.) and elution
was started with 100% water, and then water/MeOH mixtures
with gradual increase of MeOH content in a gradient elution
mode of analysis. All fractions were subjected to antifungal
assay. Activity was traced to fractions 11 eluted with 90%
MeOH (17 mg) and 12 eluted with 100% MeOH (44 mg).
The two fractions were combined after TLC screening and
subjected to centrifugal preparative TLC (CPTLC) using
Chromatotron (Harrison Research Inc. model 7924), 2 mm sil-
ica gel P254 disc and 10% EtOAc in hexane as eluting system.
Pure UV active zone was collected and dried to afford 15 mg
of pure semisolid compound F-12 with Rf value = 0.47 (Silica
gel, 20% EtOAc inn-hexane) (see Fig. 1)., J in Hz).a
Pos. C6D6
1H NMR 13C NMR
2 2.83 (d, J= 6.5) 59.2
3 5.90 (dt, J= 6.6, 16.0) 139.4
4 5.59 (d, J= 16.0) 112.9
5 – 77.8
6 – 98.5
7 – 27.8
8–10 1.20 (s, 9H) 30.8
10 3.64 (s, 2H) 60.1
20 – 134.9
30 7.28 (m) 127.1
40 7.34 (t, J= 7.0) 125.6
50 8.32 (d, J= 8.5) 125.0
50a – 134.1
60 7.66 (d, J= 8.0) 128.4
70 7.20 (t, J= 7.3) 125.0
80 7.28 (m) 125.5
90 7.59 (d, J= 8.0) 128.0
90a – 132.7
N-CH3 1.96 (s, 3H) 41.6
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C21H25N; white semi solid; [a]D = 16.8 (c= 0.0004, CHCl3).
UV kmax (CHCl3) 295 (sh), 284, 274, 240 nm.
1H and 13C NMR
(CDCl3 and C6D6): Table 1. HRESIMS m/z 292.2065 [M
++1]
(calc. for [C21H25N + H] 292.2065).
3. Results and discussion
HRESIMS showed an [M++1] at m/z 292.2065 for the molec-
ular formula C21H25N. The
13C NMR spectrum of F-12 in
CDCl3 (Table 1) showed 19 signals indicating that 3 carbon
atoms were magnetically equivalent. The carbon signal at dC
31.7 ppm correlated with the 1H NMR singlet at dH 1.07 inte-
grated for 9 protons as well as the quaternary carbon signal at
dC 29.0 was assigned for a tert-butyl moiety. The singlet at dH
1.07 showed 3 bond correlations with the acetylenic quater-
nary carbon signal at dC 99.4 ppm in an HMBC experiment
(Fig. 2). Two vinylic carbons at dC 139.4 and 114.9 ppm corre-
lated with the proton signals at dH 5.90 (dt)(H3) and 5.59 (d)
(H4) respectively. The J value = 15.8 Hz was indicative for
the trans orientation between the two protons. The upfield
doublet showed HMBC correlation with two acetylenic car-
bons (Fig. 2). COSY experiment clarified the coupling between
the vinylic double triplet with the N-CH2 protons doublet at
dH 2.97 ppm. In turn HMBC correlation was observed
between the N-CH2 doublet at dH 2.97 ppm and both
N-CH3 (dH 1.95 (s), dC 42.64) and N-CH2 (dH 3.62 (s), dC
60.5). The rest of proton and carbon signals in the spectra of
F-12 was assigned for mono substituted naphthalene nucleus
by careful analysis of the 1H, 13C NMR, COSY, HSQC and
HMBC in both CDCl3 and C6D6 (Table 1).
From the above discussion the structure of ‘‘F12” is identi-
cal with that of terbinafine. Terbinafine is the first oral antimy-
cotic from the allylamine family discovered in 1983 and
approved in 1996 in the US (Abdel-Rahman and Nahata,
1997) and act by inhibiting the synthesis of ergosterol (Ryder
and Dupont, 1985). This compound was synthetically devel-
oped by Novartis under the trade name Lamisil (Abdel-
Rahman and Nahata, 1997, www.fda.gov). However, this is
the first report for the discovery of terbinafine from microbial
culture medium and may enable the production of this active
compound for industry from natural sources.N
Figure 2 HMBC correlations of ‘‘F-12”.
Please cite this article in press as: Abdel-Kader, M.S., Muharram, M.M. New micr
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The systemic antifungal allylamine terbinafine developed syn-
thetically by Novartis under the name Lamisil is now
reported for the first time from natural source. The compound
was isolated from the culture media of Streptomyces sp. KH-
F12 isolated from soil sample collected from Adilamm,
KSA. The structure was elucidated utilizing spectroscopic data
such as UV, 1D- and 2D-NMR and HRESIMS. Isolation
from natural source could share in providing the compound
for Pharmaceutical industry.
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